Skip to main content
SpringerLink
Log in

Creutzfeldt-Jakob Disease and its Variants

  • Chapter
  • First Online:
Multiple Sclerosis, Mad Cow Disease and Acinetobacter

  • 833 Accesses

Abstract

Creutzfeldt-Jakob disease or spastic pseudosclerosis was a term applied by Jakob to a set of patients first described by Creutzfeldt (1920).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Anderson RM, Donnelly CA, Ferguson NM, Woolhouse MEJ, Watt CJ, Udy HJ, Mawhinney S, Dunstan SP, Southwood TRE, Wilesmith JW, Ryan JBM, Hoinville LJ, Hillerton JE, Austin AR, Wells GAH. Transmission dynamics and epidemiology of BSE in British cattle. Nature. 1996;382:779–88.

    Article  CAS  PubMed  Google Scholar 

  • Aoki T, Gibbs CJ, Sotelo J, Gajdusek CD. Heterogeneic autoantibody against neurofilament protein in sera of animals with experimental kuru and Creutzfeldt-Jakob disease and natural scrapie infection. Infect Immun. 1982;38:316–24.

    CAS  PubMed Central  PubMed  Google Scholar 

  • Cousens S, Smith PG, Ward H, Everington D, Knight RS, Zeidler M, Stewart G, Smith-Bathgate EA, Macleod MA, Mackenzie J, Wills RG. Geographical distribution of variant-Creutzfeldt-Jakob disease in Great Britain 1994–2000. Lancet. 2001;357:1002–7.

    Article  CAS  PubMed  Google Scholar 

  • Gajdusek DC, Gibbs CJ, Alpers M. Transmission and passage of experimental kuru to chimpanzees. Science. 1967;155:212–4.

    CAS  PubMed  Google Scholar 

  • Galvez S, Farcas A, Monari M. Cerebrospinal fluid and serum immunoglobulins and C3 in Creutzfeldt-Jakob disease. Neurology. 1979;29:1610–2.

    Article  CAS  PubMed  Google Scholar 

  • Giese A, Brown DR, Groschup MH, Feldmann C, Haist I, Kretschmar HA. Role of microglia in neuronal cell death in prion disease. Brain Pathol. 1998;8:449–57.

    Article  CAS  PubMed  Google Scholar 

  • Jakob Uber eigenartige Erkrankungen des Zentralnervensystems mit Bemerkenswerten anatomischen Befunden. Spastische Pseudosklerose Encephalopathie mit disseminierte Degenerationsherden. Z ges Neurol Psychiater. 1920;64:146.

    Google Scholar 

  • Irani DN. The classic and variant forms of Creutzfeldt-Jakob disease. Semin Clin Neuropsychiatry. 2003;8:71–9.

    Article  PubMed  Google Scholar 

  • Klein MA, Frigg R, Flechsig E, Raeber AJ, Kalinke U, Bluethmann U, Bootz E, Suter M, Zinkernagel RM, Aguzzi A. A crucial role for B cells in neuroinvasive scrapie. Nature. 1987;390:687–90.

    Google Scholar 

  • Kohira I, Tsuji T, Ishizu H, Takao Y, Wake A, Abe K, Kuroda S. Elevation of neuron-specific enolase in serum and cerebrospinal fluid of early stage Creutzfeldt-Jaskob disease. Acta Neurol Scand. 2000;102:385–7.

    Article  CAS  PubMed  Google Scholar 

  • Kovacs GG, Gasque P, Strobel T, Lindeck-Pozza E, Strohschneider M, Ironside JW, Budka H, Guentchen M. Complement activation in human prion disease. Neurobiol Dis. 2004;15:21–8.

    Article  CAS  PubMed  Google Scholar 

  • Lewicki H, Tishon A, Homann D, Mazarquil H, Laval F, Asensio VC, Campbell IL, DeArmond S, Coon B, Teng C, Gairin JE, Oldstone MBA. T cells infiltrate the brain of murine and human transmissible spongiform encephalopathies. J Virol. 2003;77:3799–808.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Mabbott NA, Bruce ME. The immunobiology of TSE diseases. J Gen Virol. 2001;82:2307–18.

    CAS  PubMed  Google Scholar 

  • Manuelidis L, Yu ZX, Barquero N, Banquero N, Mullins B. Cells infected with scrapie and Creutzfeldt-Jakob disease agents produce intracellular 25 nm virus like particles. Proc Natl Acad Sci USA. 2007;104:1965–70.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Peden AH, Head MW, Ritchie DL, Bell JE, Ironside JW. Pre-clinical v-CJD after blood transfusion in a PRNP codon heterozygous patient. Lancet. 2004;364:527–9.

    Article  PubMed  Google Scholar 

  • Pugliatti M, Sotgiu S, Rosati G. The worldwide prevalence of multiple sclerosis. Clin Neurol Neurosurg. 2002;104:182–91.

    Article  PubMed  Google Scholar 

  • Scholz R, Lorenzen S. Phantom BSE-Gefahr. Innsbruck: Berenkamp; 2005.

    Google Scholar 

  • Sotelo J, Gibbs CJ, Gajdusek DC. Autoantibodies against axonal neurofilaments in patients with kuru and Creutzfeldt-Jakob disease. Science. 1980;210:190–3.

    Article  CAS  PubMed  Google Scholar 

  • Toh DH, Gibbs CJ, Gajdusek DC, Tutdill DD, Dahl D. The 200 and 150-kDa neurofilaments protein react with IgG autoantibodies from chimpanzees with kuru or Creutzfeldt-Jakob disease; a 62 kDa neurofilament associated protein reacts with sera from sheep with natural scrapie. Proc Natl Acad Sci U S A. 1985;82:3894–6.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Van Everbroeck B, Dewulf E, Pals P, Lübke U, Martin JJ, Cras P. The role of cytokines, astrocytes, microglia and apoptosis in Creutzfeldt-Jakob disease. Neurobiol Aging. 2002;23:59–64.

    Article  PubMed  Google Scholar 

  • Venters GA. New variant Creutzfeldt-Jakob dfisease: the epidemic that never was. Bit Med J. 2001;323:858–61.

    Article  CAS  Google Scholar 

  • Volkel D, Zimmermann K, Zerr I, Lindner T, Bodemer M, Poser S, Schwarz HS. C-reactive protein and Il-6: new marker proteins for the diagnosis of CJD in plasma? Transfusion. 2001;41:1509–14.

    Article  CAS  PubMed  Google Scholar 

  • Ward HJT, Everington D, Cousens SN, Smith-Bathgate B, Leitch M, Cooper S, et al. Risk factors for variant Creutzfeldt-Jakob disease: a case-control study. Ann Neurol. 2006;59:111–20.

    Article  PubMed  Google Scholar 

  • Wientjens DP, Davanipour Z, Hofman A, Kondo K, Mattlews WB, Will RG, Van Duijn CM. Risk factors for Creutzfeldt-Jakob disease: a re-analysis of case-control studies. Neurology. 1996;46:1287–91.

    Article  CAS  PubMed  Google Scholar 

  • Will RG, Ironside JW, Zeidler M, Cousens SN, Estibeiro K, Alperovitch A, Poser S, Pocchiari M, Hofman A, Smith PG. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet. 1996;347:921–5.

    Article  CAS  PubMed  Google Scholar 

  • Will RG, Alperovitch A, Poser S, Pocchiari M, Hoiffman A, Mitrova E, et al. Descriptiver epidemiology of Creutzfeldt-Jakob disease in six European countries. Ann Neurol. 1998;43:763–7

    Article  CAS  PubMed  Google Scholar 

  • Zerr I, Poser S. Clinical diagnosis and differential diagnosis of CJD and variant-CJD. APMIS. 2002;110:88–98.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. King’s College London, London, UK

    Alan Ebringer

Authors
  1. Alan Ebringer
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Ebringer, A. (2015). Creutzfeldt-Jakob Disease and its Variants. In: Multiple Sclerosis, Mad Cow Disease and Acinetobacter. Springer, Cham. https://doi.org/10.1007/978-3-319-02735-7_16

Download citation

Publish with us

Policies and ethics

Search

Navigation